Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Primary Care
Published in: BMC Primary Care 1/2021

Open Access 01-12-2021 | Antidepressant Drugs | Research

Swiss GPs’ preferences for antidepressant treatment in mild depression: vignette-based quantitative analysis

Authors: Michael P. Hengartner, Stefan Neuner-Jehle, Oliver Senn

Published in: BMC Primary Care | Issue 1/2021

Login to get access

Abstract

Background

GPs frequently prescribe antidepressants in mild depression. The aim of this study was to examine, how often Swiss GPs recommend antidepressants in various clinical presentations of mild depression and which factors contribute to antidepressant treatment recommendations.

Methods

We conducted an online survey among Swiss GPs with within-subject effect analysis. Alternating case vignettes described a typical female case of mild depression according to International Classification of Diseases, 10th edition criteria, with and without anxiety symptoms and sleep problems. GPs indicated for each vignette their preferred treatments (several recommendations were possible). Additionally, we assessed GP characteristics, attitudes towards depression treatments, and elements of clinical decision-making.

Results

Altogether 178 GPs completed the survey. In the initial description of a case with mild depression, 11% (95%-CI: 7%-17%) of GPs recommended antidepressants. If anxiety symptoms were added to the same case, 29% (23%-36%) recommended antidepressants. If sleep problems were mentioned, 47% (40%-55%) recommended antidepressants, and if both sleep problems and anxiety symptoms were mentioned, 63% (56%-70%) recommended antidepressants. Several factors were independently associated with increased odds of recommending antidepressants, specifically more years of practical experience, an advanced training in psychosomatic and psychosocial medicine, self-dispensation, and a higher perceived effectiveness of antidepressants. By contrast, a higher perceived influence of patient characteristics and the use of clinical practice guidelines were associated with reduced odds of recommending antidepressants.

Conclusions

Consistent with depression practice guidelines, Swiss GPs rarely recommended antidepressants in mild depression if no co-indications (i.e., sleep problems and anxiety symptoms) were depicted. However, presence of sleep problems and anxiety symptoms, many years of practical experience, overestimation of antidepressants’ effectiveness, self-dispensation, an advanced training in psychosomatic and psychosocial medicine, and non-use of clinical practice guidelines may independently lead to antidepressant over-prescribing.
Appendix
Available only for authorised users
Literature
1.
Olfson M, Blanco C, Marcus SC. Treatment of Adult Depression in the United States. JAMA Intern Med. 2016;176(10):1482–91.PubMedCrossRef
2.
Sundquist J, Ohlsson H, Sundquist K, Kendler KS. Common adult psychiatric disorders in Swedish primary care where most mental health patients are treated. BMC Psychiatry. 2017;17(1):235.PubMedPubMedCentralCrossRef
3.
Coupland C, Hill T, Morriss R, Moore M, Arthur A, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in people aged 20–64 years: cohort study using a primary care database. BMC Med. 2018;16(1):36.PubMedPubMedCentralCrossRef
4.
Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, Vos T, Whiteford HA. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10(11):e1001547.PubMedPubMedCentralCrossRef
5.
Berardi D, Menchetti M, Cevenini N, Scaini S, Versari M, De Ronchi D. Increased recognition of depression in primary care. Comparison between primary-care physician and ICD-10 diagnosis of depression. Psychother Psychosom. 2005;74(4):225–30.PubMedCrossRef
6.
Mojtabai R. Clinician-identified depression in community settings: concordance with structured-interview diagnoses. Psychother Psychosom. 2013;82(3):161–9.PubMedCrossRef
7.
Martinez C, Rietbrock S, Wise L, Ashby D, Chick J, Moseley J, Evans S, Gunnell D. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ. 2005;330(7488):389.PubMedPubMedCentralCrossRef
8.
Cameron IM, Reid IC, MacGillivray SA. Efficacy and tolerability of antidepressants for sub-threshold depression and for mild major depressive disorder. J Affect Disord. 2014;166:48–58.PubMedCrossRef
9.
Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, Fawcett J. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303(1):47–53.PubMedPubMedCentralCrossRef
10.
Hermens ML, van Hout HP, Terluin B, Ader HJ, Penninx BW, van Marwijk HW, Bosmans JE, van Dyck R, de Haan M. Clinical effectiveness of usual care with or without antidepressant medication for primary care patients with minor or mild-major depression: a randomized equivalence trial. BMC Med. 2007;5:36.PubMedPubMedCentralCrossRef
11.
Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA. The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature. Psychother Psychosom. 2016;85(5):270–88.PubMedCrossRef
12.
Alberti S, Chiesa A, Andrisano C, Serretti A. Insomnia and somnolence associated with second-generation antidepressants during the treatment of major depression: a meta-analysis. J Clin Psychopharmacol. 2015;35(3):296–303.PubMedCrossRef
13.
Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol. 2009;29(3):259–66.PubMedCrossRef
14.
DGPPN: S3-Leitlinie/Nationale Versorgungsleitlinie Unipolare Depression. Version 5. Berlin: DGPPN; 2015.
15.
Holsboer-Trachsler E, Hättenschwiler J, Beck J, Brand S, Hemmeter UM, Ekkehard Keck M, Rennhard S, Hatzinger M, Merlo M, Bondolfi G, et al. Die Akutbehandlung depressiver Episoden. Swiss Medical Forum. 2016;16(35):716–24.CrossRef
16.
NICE: Depression in adults: recognition and management [nice.org.uk/guidance/cg90]
17.
Baumeister H. Inappropriate prescriptions of antidepressant drugs in patients with subthreshold to mild depression: time for the evidence to become practice. J Affect Disord. 2012;139(3):240–3.PubMedCrossRef
18.
Jureidini J, Tonkin A. Overuse of antidepressant drugs for the treatment of depression. CNS Drugs. 2006;20(8):623–32.PubMedCrossRef
19.
Macdonald S, Morrison J, Maxwell M, Munoz-Arroyo R, Power A, Smith M, Sutton M, Wilson P. “A coal face option”: GPs’ perspectives on the rise in antidepressant prescribing. Brit J Gen Pract. 2009;59(566):658–9.CrossRef
20.
Middleton H, Moncrieff J. “They won’t do any harm and might do some good”: time to think again on the use of antidepressants? Br J Gen Pract. 2011;61(582):47–9.PubMedPubMedCentralCrossRef
21.
Davidson SK, Romaniuk H, Chondros P, Dowrick C, Pirkis J, Herrman H, Fletcher S, Gunn J. Antidepressant treatment for primary care patients with depressive symptoms: Data from the diamond longitudinal cohort study. Aust N Z J Psychiatry. 2020;54(4):367–81.PubMedCrossRef
22.
Hyde J, Calnan M, Prior L, Lewis G, Kessler D, Sharp D. A qualitative study exploring how GPs decide to prescribe antidepressants. Br J Gen Pract. 2005;55(519):755–62.PubMedPubMedCentral
23.
Johnson CF, Williams B, MacGillivray SA, Dougall NJ, Maxwell M. “Doing the right thing”: factors influencing GP prescribing of antidepressants and prescribed doses. BMC Fam Pract. 2017;18(1):72.PubMedPubMedCentralCrossRef
24.
Eysenbach G. Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6(3):e34.PubMedPubMedCentralCrossRef
25.
World Health Organization. International Classification of Diseases ICD-10. 10th ed. Geneva: World Health Organization; 1992.
26.
Chmiel C, Bhend H, Senn O, Zoller M, Rosemann T, study-group F. The FIRE project: a milestone for research in primary care in Switzerland. Swiss Medical Weekly. 2011;140:w13142.PubMed
27.
Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44(4):1049–60.PubMedCrossRef
28.
Trautmann S, Beesdo-Baum K, Knappe S, Einsle F, Knothe L, Wieder G, Venz J, Rummel-Kluge C, Heinz I, Koburger N, et al. The Treatment of Depression in Primary Care A Cross-sectional Epidemiological Study. Deutsches Arzteblatt International. 2017;114(43):721–8.PubMedPubMedCentral
29.
Brietzke E, Vazquez GH, Kang MJY, Soares CN. Pharmacological treatment for insomnia in patients with major depressive disorder. Expert Opin Pharmacother. 2019;20(11):1341–9.PubMedCrossRef
30.
Everitt H, Baldwin DS, Stuart B, Lipinska G, Mayers A, Malizia AL, Manson CC, Wilson S. Antidepressants for insomnia in adults. Cochrane Database Syst Rev. 2018;5:CD010753.PubMed
31.
Baldwin DS, Anderson IM, Nutt DJ, Allgulander C, Bandelow B, den Boer JA, Christmas DM, Davies S, Fineberg N, Lidbetter N, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol. 2014;28(5):403–39.PubMedCrossRef
32.
33.
Lewis G, Duffy L, Ades A, Amos R, Araya R, Brabyn S, Button KS, Churchill R, Derrick C, Dowrick C, et al. The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial. Lancet Psychiat. 2019;6(11):903–14.CrossRef
34.
35.
Gartlehner G, Gaynes BN, Amick HR, Asher GN, Morgan LC, Coker-Schwimmer E, Forneris C, Boland E, Lux LJ, Gaylord S, et al. Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments for Major Depression: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2016;164(5):331–41.PubMedCrossRef
36.
Linde K, Berner MM, Kriston L. St John’s wort for major depression. Cochrane Database Syst Rev. 2008;4:CD000448.
37.
Lambert MJ, Barley DE. Research summary on the therapeutic relationship and psychotherapy outcome. Psychotherapy. 2001;38(4):357–61.CrossRef
38.
Wampold BE. How important are the common factors in psychotherapy? An update World Psychiatry. 2015;14(3):270–7.PubMedCrossRef
39.
Hengartner MP, Ploderl M. Statistically Significant Antidepressant-Placebo Differences on Subjective Symptom-Rating Scales Do Not Prove That the Drugs Work: Effect Size and Method Bias Matter! Front Psychiatry. 2018;9:517.PubMedPubMedCentralCrossRef
40.
41.
Hengartner MP. Is there a genuine placebo effect in acute depression treatments? A reassessment of regression to the mean and spontaneous remission. BMJ Evid Based Med. 2020;25(2):46–8.PubMedCrossRef
42.
Blozik E, Rapold R, Reich O. Prescription of potentially inappropriate medication in older persons in Switzerland: does the dispensing channel make a difference? Risk Manag Healthc Policy. 2015;8:73–80.PubMedPubMedCentralCrossRef
43.
Rachamin Y, Meier R, Valeri F, Rosemann T, Muheim L. Physician-dispensing as a determinant of clinical and process measurements in patients at increased cardiovascular risk: a cross-sectional study in Swiss general practice. Health Policy. 2021;125(10):1305–10.PubMedCrossRef
44.
Lyu H, Xu T, Brotman D, Mayer-Blackwell B, Cooper M, Daniel M, Wick EC, Saini V, Brownlee S, Makary MA. Overtreatment in the United States. PLoS One. 2017;12(9):e0181970.PubMedPubMedCentralCrossRef
45.
Jungo KT, Meier R, Valeri F, Schwab N, Schneider C, Reeve E, Spruit M, Schwenkglenks M, Rodondi N, Streit S. Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trial. BMC Fam Pract. 2021;22(1):123.PubMedPubMedCentralCrossRef
46.
Simon GE, VonKorff M. Recognition, management, and outcomes of depression in primary care. Arch Fam Med. 1995;4(2):99–105.PubMedCrossRef
47.
Stegenga BT, Kamphuis MH, King M, Nazareth I, Geerlings MI. The natural course and outcome of major depressive disorder in primary care: the PREDICT-NL study. Soc Psychiatry Psychiatr Epidemiol. 2012;47(1):87–95.PubMedCrossRef
48.
Ten Have M, de Graaf R, van Dorsselaer S, Tuithof M, Kleinjan M, Penninx B. Recurrence and chronicity of major depressive disorder and their risk indicators in a population cohort. Acta Psychiatr Scand. 2018;137(6):503–15.PubMedCrossRef
49.
Iglesias-Gonzalez M, Aznar-Lou I, Penarrubia-Maria MT, Gil-Girbau M, Fernandez-Vergel R, Alonso J, Serrano-Blanco A, Rubio-Valera M. Effectiveness of watchful waiting versus antidepressants for patients diagnosed of mild to moderate depression in primary care: A 12-month pragmatic clinical trial (INFAP study). Eur Psychiatry. 2018;53:66–73.PubMedCrossRef
Metadata
Title
Swiss GPs’ preferences for antidepressant treatment in mild depression: vignette-based quantitative analysis
Authors
Michael P. Hengartner
Stefan Neuner-Jehle
Oliver Senn
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Primary Care / Issue 1/2021
Electronic ISSN: 2731-4553
DOI
https://doi.org/10.1186/s12875-021-01621-7

Other articles of this Issue 1/2021

BMC Primary Care 1/2021 Go to the issue

Research article

Construction of a patient decision aid for the treatment of uncomplicated urinary tract infection in primary care

Research

A pragmatic randomized trial of a primary care antimicrobial stewardship intervention in Ontario, Canada

Research

Telehealth challenges during COVID-19 as reported by primary healthcare physicians in Quebec and Massachusetts

Research article

Influence of organization and demographic characteristics of primary care practices on continuity of care: analysis of a retrospective cohort from 287 primary care practices covering about 6 million people in Catalonia

Research article

The survey visit as a key evaluative event in accreditation–a qualitative study of survey visit experiences among surveyors and general practice professionals

Research article

Gap between desired and self-determined roles of general practitioners: a multicentre questionnaire study in Japan